Robert M Fetsuga
Examiner (ID: 1858, Phone: (571)272-4886 , Office: P/3993 )
Most Active Art Unit | 3751 |
Art Unit(s) | 2899, 2403, 3751, 3993, 1751, 3105 |
Total Applications | 2201 |
Issued Applications | 1476 |
Pending Applications | 73 |
Abandoned Applications | 652 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8756044
[patent_doc_number] => 20130090349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-11
[patent_title] => 'Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist'
[patent_app_type] => utility
[patent_app_number] => 13/645595
[patent_app_country] => US
[patent_app_date] => 2012-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 27603
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13645595
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/645595 | Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist | Oct 4, 2012 | Abandoned |
Array
(
[id] => 8767144
[patent_doc_number] => 20130095181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIODIN-2-YL)BENZOIC ACID AND ADMINISTRATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/646130
[patent_app_country] => US
[patent_app_date] => 2012-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 29243
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 48
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13646130
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/646130 | PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIODIN-2-YL)BENZOIC ACID AND ADMINISTRATION THEREOF | Oct 4, 2012 | Abandoned |
Array
(
[id] => 11176937
[patent_doc_number] => 09408913
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Composition and dressing for wound treatment'
[patent_app_type] => utility
[patent_app_number] => 14/344403
[patent_app_country] => US
[patent_app_date] => 2012-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7763
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344403
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/344403 | Composition and dressing for wound treatment | Sep 11, 2012 | Issued |
Array
(
[id] => 9831850
[patent_doc_number] => 08940662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-27
[patent_title] => 'Methods for controlling pests'
[patent_app_type] => utility
[patent_app_number] => 13/607249
[patent_app_country] => US
[patent_app_date] => 2012-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15545
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13607249
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/607249 | Methods for controlling pests | Sep 6, 2012 | Issued |
Array
(
[id] => 8683955
[patent_doc_number] => 20130052239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'Formulation'
[patent_app_type] => utility
[patent_app_number] => 13/602735
[patent_app_country] => US
[patent_app_date] => 2012-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17754
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 48
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13602735
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/602735 | Formulation | Sep 3, 2012 | Abandoned |
Array
(
[id] => 8522276
[patent_doc_number] => 20120321684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'Color Cosmetic'
[patent_app_type] => utility
[patent_app_number] => 13/597154
[patent_app_country] => US
[patent_app_date] => 2012-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3445
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13597154
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/597154 | Color Cosmetic | Aug 27, 2012 | Abandoned |
Array
(
[id] => 10380517
[patent_doc_number] => 20150265524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'NAIL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/416438
[patent_app_country] => US
[patent_app_date] => 2012-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8089
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416438
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/416438 | NAIL COMPOSITIONS | Aug 15, 2012 | Abandoned |
Array
(
[id] => 9843682
[patent_doc_number] => 08945593
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-03
[patent_title] => 'Orally ingested metabolic enhancer in oral thin film container'
[patent_app_type] => utility
[patent_app_number] => 13/565903
[patent_app_country] => US
[patent_app_date] => 2012-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 2731
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13565903
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/565903 | Orally ingested metabolic enhancer in oral thin film container | Aug 2, 2012 | Issued |
Array
(
[id] => 9736169
[patent_doc_number] => 20140271881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'ANTISEPTIC COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/234193
[patent_app_country] => US
[patent_app_date] => 2012-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4106
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14234193
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/234193 | ANTISEPTIC COMPOSITION | Aug 1, 2012 | Abandoned |
Array
(
[id] => 8495531
[patent_doc_number] => 20120294939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'DIRECT COMPRESSION FORMULATION AND PROCESS'
[patent_app_type] => utility
[patent_app_number] => 13/562415
[patent_app_country] => US
[patent_app_date] => 2012-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13875
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13562415
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/562415 | DIRECT COMPRESSION FORMULATION AND PROCESS | Jul 30, 2012 | Abandoned |
Array
(
[id] => 8585830
[patent_doc_number] => 20130004651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'SUSTAINED DRUG RELEASE FROM BODY IMPLANTS USING NANOPARTICLE-EMBEDDED POLYMERIC COATING MATERIALS'
[patent_app_type] => utility
[patent_app_number] => 13/560730
[patent_app_country] => US
[patent_app_date] => 2012-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6142
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13560730
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/560730 | SUSTAINED DRUG RELEASE FROM BODY IMPLANTS USING NANOPARTICLE-EMBEDDED POLYMERIC COATING MATERIALS | Jul 26, 2012 | Abandoned |
Array
(
[id] => 8940544
[patent_doc_number] => 20130190341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'HIGH BIOAVAILABILITY OPIOID FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/558463
[patent_app_country] => US
[patent_app_date] => 2012-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19017
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13558463
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/558463 | HIGH BIOAVAILABILITY OPIOID FORMULATIONS | Jul 25, 2012 | Abandoned |
Array
(
[id] => 8477871
[patent_doc_number] => 20120277278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'PHENYLBUTAZONE CARRIER FORMULATION SHOWING INCREASED BIOACTIVITY IN ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 13/543948
[patent_app_country] => US
[patent_app_date] => 2012-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4935
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13543948
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/543948 | Phenylbutazone carrier formulation showing increased bioactivity in animals | Jul 8, 2012 | Issued |
Array
(
[id] => 8464605
[patent_doc_number] => 20120269772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'LIPID DEPOT FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/537096
[patent_app_country] => US
[patent_app_date] => 2012-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18416
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13537096
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/537096 | Lipid depot formulations | Jun 28, 2012 | Issued |
Array
(
[id] => 8708681
[patent_doc_number] => 20130065970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'COMPOSITIONS AND PRODUCTS CONTAINING ESTOLIDE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/534424
[patent_app_country] => US
[patent_app_date] => 2012-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20032
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13534424
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/534424 | COMPOSITIONS AND PRODUCTS CONTAINING ESTOLIDE COMPOUNDS | Jun 26, 2012 | Abandoned |
Array
(
[id] => 9490652
[patent_doc_number] => 20140141057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'Adhesive or Hydrocolloid Containing Vegetable Oil'
[patent_app_type] => utility
[patent_app_number] => 14/128658
[patent_app_country] => US
[patent_app_date] => 2012-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5502
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128658
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/128658 | Adhesive or Hydrocolloid Containing Vegetable Oil | Jun 18, 2012 | Abandoned |
Array
(
[id] => 8370233
[patent_doc_number] => 20120219622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'DPP IV INHIBITOR FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/467505
[patent_app_country] => US
[patent_app_date] => 2012-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3729
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467505
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/467505 | DPP IV INHIBITOR FORMULATIONS | May 8, 2012 | Abandoned |
Array
(
[id] => 9615701
[patent_doc_number] => 20140205559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'ANTIFUNGAL COMPOSITIONS FOR THE TREATMENT OF SKIN AND NAILS'
[patent_app_type] => utility
[patent_app_number] => 14/116360
[patent_app_country] => US
[patent_app_date] => 2012-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26966
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116360
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116360 | Antifungal compositions for the treatment of skin and nails | May 7, 2012 | Issued |
Array
(
[id] => 8696937
[patent_doc_number] => 20130058946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'Seizure and Migraine Treatments using Denosumab'
[patent_app_type] => utility
[patent_app_number] => 13/462661
[patent_app_country] => US
[patent_app_date] => 2012-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 25839
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462661
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/462661 | Seizure and Migraine Treatments using Denosumab | May 1, 2012 | Abandoned |
Array
(
[id] => 8359717
[patent_doc_number] => 20120214876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'Seizure and Migraine Treatments using the Bone Homeostasis Drug Cinacalcet'
[patent_app_type] => utility
[patent_app_number] => 13/462320
[patent_app_country] => US
[patent_app_date] => 2012-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 25833
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462320
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/462320 | Seizure and Migraine Treatments using the Bone Homeostasis Drug Cinacalcet | May 1, 2012 | Abandoned |